Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$469M Buy
4,383,866
+1,624,535
+59% +$179M 4.53% 9
2026
Q1
$290M Buy
2,759,331
+498,271
+22% +$58.5M 3.22% 14
2025
Q4
$282M Sell
2,261,060
-1,999,786
-47% -$238M 3.07% 12
2025
Q3
$511M Sell
4,260,846
-309,718
-7% -$32.7M 5.39% 7
2025
Q2
$420M Buy
4,570,564
+339,328
+8% +$31M 4.3% 10
2025
Q1
$372M Sell
4,231,236
-97,656
-2% -$9.6M 4.29% 10
2024
Q4
$401M Sell
4,328,892
-86,766
-2% -$8.35M 4.63% 9
2024
Q3
$410M Buy
4,415,658
+475,305
+12% +$39.9M 4.13% 13
2024
Q2
$295M Sell
3,940,353
-295,084
-7% -$23.5M 2.98% 17
2024
Q1
$365M Buy
4,235,437
+842,172
+25% +$64.4M 3.53% 13
2023
Q4
$235M Buy
+3,393,265
New +$205M 2.54% 17

Other funds holding CRH

John Armitage's CRH Position: Q2 2026 in Review

John Armitage increased its CRH (CRH) stake by 59% in Q2 2026, buying an estimated $179M and bringing the position to 4,383,866 shares worth $469M. The position accounts for 4.53% of the portfolio, ranked #9.

John Armitage first reported a position in CRH in Q4 2023 and has held it in 11 quarters since. The position peaked at $511M in Q3 2025. 1,023 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • John Armitage held 4,383,866 shares of CRH worth $469M as of Q2 2026.
  • John Armitage bought 1,624,535 CRH shares in Q2 2026, an estimated $179M.
  • CRH made up 4.53% of John Armitage's portfolio in Q2 2026, its #9 holding.
  • John Armitage first reported a position in CRH in Q4 2023 and has held it in 11 quarters since.
  • John Armitage's CRH position peaked at $511M in Q3 2025.
  • 1,023 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Egerton Capital (UK)'s 13F filing for Q2 2026, filed 21 Jul 2026.